Camad, Nadzman .
HRN: 21-88-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2025
CEFUROXIME 1.5GM (VIAL)
10/04/2025
10/04/2025
IV
1500mg
On Call To OR
For CS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes